ArticleActive
Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58187
Policy Summary
Billing for MolDX prognostic and predictive molecular classifiers for bladder cancer must follow LCD L38649 and include selection of the appropriate CPT and ICD-10-CM codes. Submit the DEX Z-Code identifier adjacent to the CPT code in the specified electronic or paper claim fields (Loop 2400/SV101-7, Item 19, SV202-7, Block 80) and report one unit of service; do not add extra characters on the SV101-7 line.
Coverage Criteria Preview
Key requirements from the full policy
"Molecular prognostic and predictive classifier testing for bladder cancer is billable when performed consistent with the associated MolDX LCD L38649."
Sign up to see full coverage criteria, indications, and limitations.